Purple Biotech Ltd (TLV:PPBT)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1.000
0.00 (0.00%)
Aug 12, 2026, 10:15 AM IDT

Purple Biotech Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1922407894213
Market Cap Growth
-12.10%-44.71%-48.30%-17.30%-55.64%-1.36%
Enterprise Value
1-111819-2169
Last Close Price
0.010.010.080.320.511.20

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
0.510.720.340.630.571.05
P/TBV Ratio
1.272.972.213.521.021.54

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.030.010.010.010.01
Net Debt / Equity Ratio
-0.49-0.97-0.25-0.44-0.67-0.71
Net Debt / EBITDA Ratio
0.761.340.780.681.412.63
Net Debt / FCF Ratio
0.771.650.580.761.893.02
Quick Ratio
3.421.242.141.594.5511.11
Current Ratio
3.701.272.231.634.7111.41
Return on Equity (ROE)
-111.13%-124.46%-21.66%-49.09%-38.79%-24.61%
Return on Assets (ROA)
-20.31%-15.97%-16.60%-28.14%-22.63%-14.55%
Return on Capital Employed (ROCE)
-63.70%-71.00%-32.70%-64.40%-47.50%-27.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-391.34%-377.18%-65.38%-91.76%-80.75%-26.88%
FCF Yield
-124.02%-80.89%-129.73%-91.98%-62.47%-22.47%
Buyback Yield / Dilution
-267.67%-192.79%-48.15%-22.41%-2.92%-52.76%